Evidence map›Paper›PMID 39027036›Full record

ArticleRSC advances2024

Assessment of wafer scale MoS

Michael Curtis, Olivia Maryon, Nicholas McKibben, Josh Eixenberger, Chen Chen, Karthik Chinnathambi, Sergej Pasko, Salim El Kazzi, Joan M Redwing, David Estrada

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michael CurtisMicron School of Materials Science and Engineering, Boise State University Boise ID USA 83725 daveestrada@boisestate.edu.ORCID https://orcid.org/0000-0003-1607-332X
Olivia MaryonMicron School of Materials Science and Engineering, Boise State University Boise ID USA 83725 daveestrada@boisestate.edu.
Nicholas McKibbenMicron School of Materials Science and Engineering, Boise State University Boise ID USA 83725 daveestrada@boisestate.edu.ORCID https://orcid.org/0000-0002-1546-5682
Josh EixenbergerDepartment of Physics, Boise State University Boise ID 83725 USA.
Chen Chen2D Crystal Consortium Materials Innovation Platform, Materials Research Institute, The Pennsylvania State University University Park PA 16802 USA.
Karthik ChinnathambiBoise State Center for Materials Characterization, Boise State University Boise ID 83725 USA.ORCID https://orcid.org/0000-0002-4078-1310
Sergej PaskoAIXTRON SE Herzogenrath Germany.
Salim El KazziAIXTRON SE Herzogenrath Germany.
Joan M Redwing2D Crystal Consortium Materials Innovation Platform, Materials Research Institute, The Pennsylvania State University University Park PA 16802 USA.
David EstradaMicron School of Materials Science and Engineering, Boise State University Boise ID USA 83725 daveestrada@boisestate.edu.ORCID https://orcid.org/0000-0001-5894-0773

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transition Metal Dichalcogenides (TMDs) are a unique class of materials that exhibit attractive electrical and optical properties which have generated significant interest for applications in microelectronics, optoelectronics, energy storage, and sensing. Considering the potential of these materials to impact such applications, it is crucial to develop a reliable and scalable synthesis process that is compatible with modern industrial manufacturing methods. Metal-organic chemical vapor deposition (MOCVD) offers an ideal solution to produce TMDs, due to its compatibility with large-scale production, precise layer control, and high material purity. Optimization of MOCVD protocols is necessary for effective TMD synthesis and integration into mainstream technologies. Additionally, improvements in metrology are necessary to measure the quality of the fabricated samples more accurately. In this work, we study MOCVD of wafer-scale molybdenum disulfide (MoS

Identifiers

PMID39027036
PMCPMC11255563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.